Profilo
Nicholas Opie is the founder of Synchron, Inc. He is currently the Chief Technology Officer & Director at SmartStent Pty Ltd.
Posizioni attive di Nicholas Opie
| Società | Posizione | Inizio |
|---|---|---|
SmartStent Pty Ltd.
 SmartStent Pty Ltd. Computer Processing HardwareElectronic Technology SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia. | Direttore Tecnico/Scientifico/R&S | - |
Synchron, Inc.
 Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
SmartStent Pty Ltd.
SmartStent Pty Ltd. Computer Processing HardwareElectronic Technology SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia. | Electronic Technology |
Synchron, Inc.
Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | Technology Services |
- Borsa valori
- Insiders
- Nicholas Opie
